Seyed Shahabeddin Sadr

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Ischemia Reperfusion Injury

Signaling Pathway

Ankylosing Spondylitis

Top Venues

Clinical and experimental pharmacology & physiology

Metabolic brain disease

Basic and clinical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Elham Zahedi, Seyed Shahabeddin Sadr, Ashkan Sanaeierad, Mehrdad Roghani
Valproate-induced murine autism spectrum disorder is associated with dysfunction of amygdala parvalbumin interneurons and downregulation of AMPK/SIRT1/PGC1α signaling. Metabolic brain disease (2023)
Safoura Khamse, Seyed Shahabeddin Sadr, Mehrdad Roghani, Mina Rashvand, Maryam Mohammadian, Narges Marefati, Elham Harati, Fatemeh Ebrahimi
The Effect of Rosmarinic Acid on Apoptosis and nNOS Immunoreactivity Following Intrahippocampal Kainic Acid Injections in Rats. Basic and clinical neuroscience 11 (1) (2020)
Parvaneh Mohseni-Moghaddam, Seyed Shahabeddin Sadr, Mehrdad Roghani, Somayeh Arabzadeh, Safoura Khamse, Elham Zamani, Marjan Hosseini, Fatemeh Moradi
Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid-induced epileptic rats by antioxidant activity and NLRP3/caspase-1 pathway inhibition. Clinical and experimental pharmacology & physiology 46 (4) (2019)